CytomX Therapeutics, Inc. (CTMX) income statement
CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.03−0.02 (-0.98%)
Close on Nov 20, 2026Market cap $442.34MP/E –Yield –
CytomX Therapeutics, Inc. financial ratios
See a number that looks wrong?